Literature DB >> 3260141

Antigenic heterogeneity within influenza A (H3N2) virus strains.

J C de Jong, F M de Ronde-Verloop, T M Veenendaal-van Herk, T F Weijers, K Bijlsma, A D Osterhaus.   

Abstract

On the basis of their antigenic properties, influenza virus strains are classified into types and subtypes, which are further subdivided into variants that differ to various degrees in haemagglutination-inhibition assays. Evidence is presented that during infection with an influenza A(H3N2) virus the respiratory tract of a human patient often harbours more than one antigenic virus variant. These variants are frequently propagated by embryonated fowl eggs and monkey cells with different efficiencies, and this may lead to the selection of different variants by either of these host systems. Also, passage of virus by a given host is sometimes attended by changes in reactivity in haemagglutination-inhibition tests. In some cases the heterogeneity described also affects the specific immunogenicity of the virus in ferrets. Virus strains cloned in monkey kidney cell cultures gave variants that were stable upon further passage. These results may have implications for antigenic and biochemical investigations of epidemiologically relevant virus variants. It is argued that the antigenic drift of influenza A(H3N2) viruses is best characterized by analyses, both with post-infection ferret antisera and with panels of monoclonal antibodies, of virus strains isolated and passaged in monkey kidney cell cultures only.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3260141      PMCID: PMC2491107     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  19 in total

1.  Evaluation of a trivalent adenovirus vaccine for prevention of acute respiratory disease in naval recruits.

Authors:  B F GUNDELFINGER; M J HANTOVER; J A BELL; C G LOOSLI; W P ROWE
Journal:  Am J Hyg       Date:  1958-09

Review 2.  The molecular basis of antigenic variation in influenza virus.

Authors:  G M Air; W G Laver
Journal:  Adv Virus Res       Date:  1986       Impact factor: 9.937

3.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

4.  Influenzavirus neuraminidase and neuraminidase-inhibition test procedures.

Authors:  M Aymard-Henry; M T Coleman; W R Dowdle; W G Laver; G C Schild; R G Webster
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

5.  Antigenic variation in three distinct determinants of an influenza type A haemagglutinin molecule.

Authors:  J W Yewdell; R G Webster; W U Gerhard
Journal:  Nature       Date:  1979-05-17       Impact factor: 49.962

6.  Genetic dimorphism in influenza viruses: characterization of stably associated hemagglutinin mutants differing in antigenicity and biological properties.

Authors:  E D Kilbourne
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

7.  Analysis of the genome of influenza A virus strains (H3N2) isolated during the epidemic season of 1982-1983.

Authors:  A I Klimov; Y Z Ghendon
Journal:  Arch Virol       Date:  1985       Impact factor: 2.574

8.  Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs.

Authors:  J S Robertson; C W Naeve; R G Webster; J S Bootman; R Newman; G C Schild
Journal:  Virology       Date:  1985-05       Impact factor: 3.616

9.  Sequential mutations in hemagglutinins of influenza B virus isolates: definition of antigenic domains.

Authors:  M Krystal; J F Young; P Palese; I A Wilson; J J Skehel; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

10.  Swine influenza viruses isolated in 1976 from man and pig contain two coexisting subpopulations with antigenically distinguishable hemagglutinins.

Authors:  A P Kendal; G R Noble; W R Dowdle
Journal:  Virology       Date:  1977-10-01       Impact factor: 3.616

View more
  5 in total

1.  Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease.

Authors:  A Holvast; A Huckriede; J Wilschut; G Horst; J J C De Vries; C A Benne; C G M Kallenberg; M Bijl
Journal:  Ann Rheum Dis       Date:  2005-12-01       Impact factor: 19.103

2.  Hyper-antigenic variation occurs with human rhinovirus type 17.

Authors:  L J Patterson; V V Hamparian
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

3.  Antigenic and genetic evolution of swine influenza A (H3N2) viruses in Europe.

Authors:  J C de Jong; D J Smith; A S Lapedes; I Donatelli; L Campitelli; G Barigazzi; K Van Reeth; T C Jones; G F Rimmelzwaan; A D M E Osterhaus; R A M Fouchier
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

4.  Neutralization enzyme immunoassay for influenza virus.

Authors:  C A Benne; M Harmsen; J C De Jong; C A Kraaijeveld
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

5.  Effect of influenza A/equine/H3N8 virus isolate variation on the measurement of equine antibody responses.

Authors:  J R Bogdan; P S Morley; H G Townsend; D M Haines
Journal:  Can J Vet Res       Date:  1993-04       Impact factor: 1.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.